Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Parenteral lipid emulsion, Single dose amino acid solution, Trace elements, Vitamins and Minerals) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Parenteral Nutrition Market Size

The global parenteral nutrition market size was valued at USD 7.78 billion in 2025 and is projected to grow from USD 8.20 billion in 2026 to USD 12.49 billion by 2034, registering a CAGR of 5.4% during the forecast period from 2026 to 2034. North America dominated the parenteral nutrition market with a market share of 38.4% in 2025.

Parenteral nutrition refers to ingesting via an intravenous line (vein). "Parenteral" is defined as "outside of the digestive tract." Parenteral feeding skips your complete digestive system, from your mouth to your anus, instead of enteral nourishment, administered by a tube to your stomach or small intestine. Parenteral nourishment may be necessary for a short while under certain medical circumstances. Some patients use it as a dietary supplement, while others require intravenous calorie infusions.

Parenteral nutrition (PN) is the intravenous administration of nutrition for patients who cannot eat or absorb enough food through tube-feeding formula or orally to maintain good nutrition. This nutrition may include protein, carbohydrates, fat, minerals, electrolytes, vitamins, and other trace elements. Receiving the proper nourishment promptly can prevent complications and play a crucial role in a patient's recovery. Total Parenteral Nutrition (TPN) is another name for parenteral nutrition.

Nutrient Type Analysis

The global market is bifurcated into carbohydrates, parenteral lipid emulsion, single-dose amino acid solution, trace elements, vitamins, and minerals.

The single-dose amino segment dominates the global market and is projected to exhibit a CAGR of 5.2% over the forecast period. Amino acids are biochemical substances that are a necessary component for forming proteins; they are made up of an amine group and a carboxylic group. Kwashiorkor and marasmus are two disorders caused by a protein deficit. Due to a lack of resources, expertise, and poor economic conditions, this is a significant issue in developing nations. As a result, this segment's target market is emerging countries. To keep the undernourished's weight stable, single doses of amino acids, vitamins, dextrose, and trace elements are given to them.

Single-dose amino acid delivery must be combined with a suitable energy source for optimum absorption. Among the single-dosage amino acid solutions on the market are Aminosyn (produced by Hospira, Inc.) and Nirmin (produced by Nirlife Pharma). Combinations of amino acids supply both essential and optional amino acids; as a result, the standard component serves as a complete parenteral nutrition for the body's general biological operation.

Request Customizationto receive a tailored report.

Speak to an Analystto discuss market opportunities.

Regional Insights

Based on region, the global parenteral nutrition market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant market shareholder and is estimated to exhibit a CAGR of 6.4% over the forecast period. This is because the healthcare industry spends much money on research, there are technologically advanced medical devices, and partnerships between the medical device industry, regulatory agencies, universities, and other organizations. Additionally, the region is likely to have higher consumption rates due to the rising prevalence of numerous chronic conditions, the availability of advanced medical facilities, and good reimbursement regulations. Several factors are anticipated to drive the market, including the high natality rate, the rising rate of preterm births, the rising prevalence of cancer, and the rising adoption of parenteral nutrition products in healthcare settings for chronically ill geriatric patients. Patients' oral food intake is impacted by Crohn's disease, esophageal cancer, ulcerative colitis, gastric cancer, head and neck cancer, and laryngeal cancer.

Further, the demand for parenteral nourishment is anticipated to increase as these disorders become more prevalent. There are many older adults in this area, many chronic diseases, and healthcare costs are very high, publicly and privately. As a result, policymakers are focusing on managing chronic diseases, which is anticipated to benefit the market for parenteral nutrition.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Fastest-Growing Region

Europe is anticipated to exhibit a CAGR of 5.2% over the forecast period. The expansion of personalized nutrition in this area is driven by the rising trend of customizing food to achieve a healthier diet, awareness of healthy foods, and promoting health and nutrition. The personalized approach toward health and wellness helps achieve specific goals within a specified time frame. Furthermore, the increasing innovations in customer-facing technologies give customers access to information about customized nutritional solutions. The region's growing popularity of personalized nutrition has caused a major shift in food consumption patterns. The rising demand for natural foods is also a key factor in the market.

Moreover, market players are constantly working on personalized nutrition and health products, which will drive the personalized nutrition market in this region. Inadequate nutrition is contributing to lifestyle disorders, particularly among the elderly population, which is driving the retail sales of nutrition and health products in the region.

Asia-Pacific has emerged as one of the fastest-growing regions in the global market. Chronic diseases related to bad eating habits and increased demand for cost-effective treatment are projected to boost market expansion. Malnutrition, caused by rising population, poverty, and insufficient nutrition awareness, drives market demand. The market is predicted to develop due to large unmet healthcare demands, high out-of-pocket healthcare spending, and rising purchasing power to acquire technologically sophisticated healthcare services. Preterm babies are likely to boost regional market demand. India, China, Nigeria, Pakistan, and Indonesia have the most preterm births, according to WHO.

Additionally, the market will be driven by rising healthcare spending and improved healthcare infrastructure in China, Japan, India, and Singapore. Asia Pacific has the greatest market share because of important players, including Abbott, Nestlé, Danone, and Fresenius Kabi, and their substantial revenue. Asia Pacific includes Japan, China, India, and Australia. The region's patient pool and geriatric population are growing. Lifestyle changes include increasing cancer, diabetes, gastrointestinal, and autoimmune diseases. This will boost the demand for clinical nutrition products for chronic disease diet control.

In Latin America, the healthcare industry is underdeveloped, but attempts are made to enhance access and treatment. The market is driven by aging and chronic disease. In November 2020, the Development Bank of Latin America reported that 8% of the population was geriatric, rising to 17.5% by 2050. This region is seeing more disease-related malnutrition. Brazil drives the Latin American economy. In November 2020, the Development Bank of Latin America estimated healthcare spending at 4.1% of GDP, third after North America and Western Europe. This region's life expectancy is over 75. China and Europe are their research partners. Latin American markets are predicted to develop due to rising per capita health spending, government investment, and WHO and government initiatives. Latin America's market is predicted to grow profitably.

In the Middle East and Africa, the market growth is rapid. Due to the Middle East's changing socio-economic and political situations, healthcare enterprises will likely grow rapidly, creating RandD opportunities. Long-term conditions such as Rett syndrome, MECP2 mutation, GERD, and physical limitations are predicted to increase parenteral nutrition utilization over the forecast period to improve long-term care services in this region. According to a projection by UNFPA, CSA, and ESCWA, Arab countries' geriatric population would expand from 4.1% in 2010 to 12% in 2050. This region's expanding chronic disease burden offers market growth potential. Medical food adoption is also rising. Rising natality, malnutrition, premature births, and chronic diseases like cancer will drive the market.

List of Key and Emerging Players in Parenteral Nutrition Market